Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | S100A4 | P26447 | 1/20 | 0.41 |
| ▸ | USP5 | P45974 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | APAF1 | O14727 | 1/20 | 0.40 |
| ▸ | TDP2 | O95551 | 1/20 | 0.40 |
| ▸ | NSD2 | O96028 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7208178 | 0.94 | KIF11 (0.47) | ALDH1A1LMNASMN1; SMN2USP2GAA | |
| SCHEMBL8556395 | 0.83 | ALDH1A1 (0.46) | ALDH1A1LMNASMN1; SMN2USP2GAA | |
| SCHEMBL10080954 | 0.81 | ALDH1A1 (0.69) | ALDH1A1LMNASMN1; SMN2USP2GAA | |
| SCHEMBL28763259 | 0.77 | MT-CO2 (0.57) | ALDH1A1LMNAGAAHSD17B10KDM4E | |
| SCHEMBL22537737 | 0.76 | OXTR (0.45) | ALDH1A1LMNASMN1; SMN2USP2GAA | |
| SCHEMBL978072 | 0.75 | CYP2C9 (0.48) | ALDH1A1LMNASMN1; SMN2USP2GAA | |
| SCHEMBL7949240 | 0.75 | NPSR1 (0.45) | ALDH1A1LMNASMN1; SMN2GAACYP2C9 | |
| SCHEMBL8044893 | 0.75 | NPSR1 (0.61) | ALDH1A1LMNAS100A4HPGDMEN1 | |
| SCHEMBL7153902 | 0.75 | ESR1 (0.47) | ALDH1A1LMNAHSD17B10HIF1ATYR | |
| SCHEMBL4633234 | 0.73 | TSHR (0.56) | S100A4MEN1KMT2AMT-CO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1624500-B1 | Spiro bifluorene compounds as organic semiconductor matrix materials | NOVALED GMBH (DE) | 2016-03-16 | — | — | EP | disclosed |
| US-7540978-B2 | Use of an organic matrix material for producing an organic semiconductor material, organic semiconductor material and electronic component | NOVALED AG (DE) | 2009-06-02 | — | — | US | disclosed |
| US-7540978-B2 | Use of an organic matrix material for producing an organic semiconductor material, organic semiconductor material and electronic component | NOVALED AG (DE) | 2009-06-02 | — | — | US | disclosed |
| US-7540978-B2 | Use of an organic matrix material for producing an organic semiconductor material, organic semiconductor material and electronic component | NOVALED AG (DE) | 2009-06-02 | — | — | US | disclosed |
| US-20060049397-A1 | Use of an organic matrix material for producing an organic semiconductor material, organic semiconductor material and electronic component | NOVALED AG (DE) | 2006-03-09 | — | — | US | disclosed |
| EP-1624500-A1 | Spiro bifluorene compounds as organic semiconductor matrix materials | Novaled GmbH (DE) | 2006-02-08 | — | — | EP | disclosed |
| EP-0935691-B1 | OPTICAL BRIGHTENING AGENT | COVION ORGANIC SEMICONDUCTORS (DE) | 2004-05-26 | — | — | EP | disclosed |
| EP-0676461-B1 | Spiro compounds and their application as electroluminescence materials | COVION ORGANIC SEMICONDUCTORS (DE) | 2002-08-14 | — | — | EP | disclosed |
| EP-0935691-A1 | OPTICAL BRIGHTENING AGENT | Aventis Research & Technologies GmbH & Co. KG (DE) | 1999-08-18 | — | — | EP | disclosed |
| WO-1998018996-A1 | OPTICAL BRIGHTENING AGENT | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) | 1998-05-07 | — | — | WO | disclosed |
| EP-0676461-A2 | Spiro compounds and their application as electroluminescence materials | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-10-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060049397-A1 | Use of an organic matrix material for producing an organic semiconductor material, organic semiconductor material and electronic component | ILK, SOST, VIM | ALDH1A1 3436/4885LMNA 1601/4885SMN1; SMN2 1612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.